NovaVive Inc. is a Canadian immunobiology company that specializes in advanced veterinary immunotherapeutic products for cattle, horses, and dogs. With a focus on mycobacterium cell wall fraction technology, their regulator-approved products have been shown to lower incidence rates of clinical mastitis and metritis in dairy cows, improve pregnancy rates in cattle recipients, and treat equine endometritis. Sold to veterinarians in multiple countries, NovaVive is dedicated to providing innovative solutions for animal health.
Founded in 2014 and headquartered in Napanee, Ontario, NovaVive Inc. has established itself as a leader in the field of immunotherapy. Their cutting-edge research and development efforts have resulted in effective products that address various health concerns in livestock and companion animals. With a commitment to improving animal well-being, NovaVive continues to expand its reach and make a positive impact in the veterinary industry.
Generated from the website